# Transcode Therapeutics, Inc.: Form SCHEDULE 13D/A, filed Aug 3, 2026

- Company: [Transcode Therapeutics, Inc.](/companies/rnaz.md) (CIK 1829635)
- Form: SCHEDULE 13D/A
- Filed: 2026-08-03
- Accepted by EDGAR: Aug 3, 2026, 20:38 ET
- Period: not reported
- Accession: 0001104659-26-089819
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1829635/000110465926089819/xslSCHEDULE_13D_X02/primary_doc.xml
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1829635/000110465926089819/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1829635/000110465926089819/xslSCHEDULE_13D_X02/primary_doc.xml

Filed Aug 3, 2026.
Source: SEC EDGAR, the filing index for accession 0001104659-26-089819. Last ingested by Listed: Oct 24, 2026, 15:15 ET. No prices; not investment advice.